Holen Sie sich die Stockscreener-App
79.61
1.35%
1.06
Handel nachbörslich:
79.61
Dianthus Therapeutics Inc Aktie (DNTH) Neueste Nachrichten
[144] Dianthus Therapeutics, Inc.... | DNTH SEC FilingForm 144 - Stock Titan
Wedbush keeps outperform on Dianthus Therapeutics, Inc. (DNTH), highlights potential of Claseprubart in CIDP - MSN
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit - AOL.com
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Dianthus Therapeutics, Inc. (DNTH) reports Q4 loss, misses revenue estimates - MSN
Dianthus Therapeutics, Inc. (DNTH) stock jumps 12.0%: Will it continue to soar? - MSN
Assessing Dianthus Therapeutics (DNTH) Valuation After CAPTIVATE Milestone And Upsized Equity Offering - simplywall.st
Dianthus Therapeutics has appreciated 12-fold over two years. What's going on? - MSN
Wells Fargo Initiates Coverage on Dianthus Therapeutics - National Today
Wells Fargo & Company Initiates Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat
Wells Fargo Initiates Dianthus Therapeutics at Overweight - marketscreener.com
Wells Fargo reiterates Dianthus Therapeutics stock rating at Overweight By Investing.com - Investing.com Canada
Dianthus Therapeutics shares jump 25% after encouraging clinical trial update - MSN
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Sahm
Guggenheim reiterates buy rating for Dianthus Therapeutics (DNTH) - MSN
Wedbush Keeps Outperform on Dianthus Therapeutics, Inc. (DNTH), Highlights Potential of Claseprubart in CIDP - Insider Monkey
Biotech shares soar by 288% following a major funding round, with an early investor disclosing a $14 million cash-out - Bitget
Top 5 Boring Stocks That Make Money - Insider Monkey
[Form 4] Dianthus Therapeutics, Inc. /DE/ Insider Trading Activity - Stock Titan
William Blair Maintains Outperform on Dianthus Therapeutics (DNTH) March 2026 - Meyka
Dianthus Therapeutics closes $719M public offering - Investing.com Nigeria
HighVista Strategies Boosts Stake in Dianthus Therapeutics - National Today
HighVista Strategies LLC Buys 38,364 Shares of Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Dianthus Therapeutics Raises $719M in Upsized Offering - National Today
Dianthus Therapeutics, Inc. $DNTH is Fairmount Funds Management LLC's Largest Position - MarketBeat
Boothbay Fund Management Buys Stake in Dianthus Therapeutics - National Today
Boothbay Fund Management LLC Buys Shares of 138,963 Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Dianthus Therapeutics (DNTH) Is Up 19.4% After Early CAPTIVATE GO Decision And $719M Raise - simplywall.st
Dianthus Therapeutics Hits Early “Go” in CAPTIVATE Phase 3 CIDP Trial, Drops 600 mg Arm - MarketBeat
Braidwell LP Purchases Shares of 835,057 Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Dianthus Therapeutics announces proposed $400 million public share offering - MSN
Dianthus Therapeutics EVP Sells $2.7M in Stock - National Today
Assessing Dianthus Therapeutics (DNTH) Valuation After Early CAPTIVATE GO Decision And Premium P/B Multiple - Sahm
Dianthus Therapeutics launches $400M stock offering - Investing.com Nigeria
Integral Health Asset Management Acquires 150,000 Shares in Dianthus Therapeutics - National Today
Integral Health Asset Management LLC Buys New Stake in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Dianthus Therapeutics EVP Sells $2.76M in Stock - National Today
Dianthus therapeutics CAO sells shares for $3.56 million - Investing.com Nigeria
Dianthus therapeutics CAO sells shares for $3.56 million By Investing.com - Investing.com Australia
Insider Selling: Dianthus Therapeutics (NASDAQ:DNTH) CAO Sells 43,682 Shares of Stock - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) CEO Sells 122,918 Shares - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells $2,756,468.40 in Stock - MarketBeat
Dianthus therapeutics CEO Garcia sells $10m in shares - Investing.com
Dianthus Therapeutics EVP Randhawa sells shares for $2.76 million By Investing.com - Investing.com Nigeria
Dianthus Therapeutics EVP Randhawa sells shares for $2.76 million - Investing.com
Dianthus Therapeutics Executives Sell Off Significant Shares - TradingView
Dianthus Therapeutics closes $719M public offering By Investing.com - Investing.com Australia
Dianthus Therapeutics Announces Major Public Equity Offering - The Globe and Mail
Dianthus Therapeutics stock surges 25% on positive trial data - Investing.com Nigeria
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):